Zulueta, Zulueta L.
HRN: 19-21-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2022
AMPICILLIN 1GM (VIAL)
08/10/2022
08/16/2022
IV
2g
Q6h
PROM
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes